Literature DB >> 3028938

Requirements for growth of Epstein-Barr virus-transformed cells at low cell densities.

R F Tiebout, R W Sauerwein, W G van der Meer, F van Boxtel-Oosterhof, W P Zeijlemaker.   

Abstract

We investigated the requirements for growth of Epstein-Barr virus-transformed cells at low cell densities in a homotypic system: only Epstein-Barr virus-transformed cells or their products were used to supply feeder activity. The cloning efficiency was increased markedly under conditions favouring close cell-to-cell contact: culture in round-bottomed rather than in flat-bottomed wells or the addition of irradiated Epstein-Barr virus-transformed cells. Further enhancement was obtained by the addition of the tumour promoter phorbol-myristate acetate. Part of this effect was also induced by supernatants of Epstein-Barr virus-transformed cells, in particular when the latter had been stimulated with phorbol ester. Thus, under limiting dilution conditions, Epstein-Barr virus-transformed cells were found to be dependent upon autologous cell-mediated and soluble proliferation-stimulating signals. In such a homotypic feeder system, the cloning efficiency could be enhanced up to eight-fold; a 100% cloning efficiency could not be achieved. Evidence is presented that the residual deficit in cloning efficiency is inherent to these cell lines.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3028938      PMCID: PMC1453235     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  26 in total

1.  Clones of human lymphoblastoid cell lines producing antibody to tetanus toxoid.

Authors:  V R Zurawski; S E Spedden; P H Black; E Haber
Journal:  Curr Top Microbiol Immunol       Date:  1978       Impact factor: 4.291

2.  Requirements for the establishment of high-titered human monoclonal antibodies against tetanus toxoid using the Epstein-Barr virus technique.

Authors:  D Kozbor; J C Roder
Journal:  J Immunol       Date:  1981-10       Impact factor: 5.422

3.  Improved method for cloning human B-cell lines.

Authors:  S Hoch; P H Schur; J Schwaber
Journal:  Cell Immunol       Date:  1982-09-15       Impact factor: 4.868

4.  Autocrine secretion and malignant transformation of cells.

Authors:  M B Sporn; G J Todaro
Journal:  N Engl J Med       Date:  1980-10-09       Impact factor: 91.245

5.  An ultramicrochemical test for mycoplasmal contamination of cultured cells.

Authors:  M P Uitendaal; C H DeBruyn; M Hatanaka; P Hösli
Journal:  In Vitro       Date:  1979-02

6.  Human antibody to OFA-I, a tumor antigen, produced in vitro by Epstein-Barr virus-transformed human B-lymphoid cell lines.

Authors:  R F Irie; L L Sze; R E Saxton
Journal:  Proc Natl Acad Sci U S A       Date:  1982-09       Impact factor: 11.205

7.  Direct activation of calcium-activated, phospholipid-dependent protein kinase by tumor-promoting phorbol esters.

Authors:  M Castagna; Y Takai; K Kaibuchi; K Sano; U Kikkawa; Y Nishizuka
Journal:  J Biol Chem       Date:  1982-07-10       Impact factor: 5.157

8.  Human monoclonal autoimmune antibody produced in vitro: rheumatoid factor generated by Epstein-Barr virus-transformed cell line.

Authors:  M Steinitz; S Tamir
Journal:  Eur J Immunol       Date:  1982-02       Impact factor: 5.532

9.  Immunoglobulin expression by human B lymphocytes clonally transformed by Epstein Barr virus.

Authors:  N A Brown; G Miller
Journal:  J Immunol       Date:  1982-01       Impact factor: 5.422

10.  The requirement for lymphocyte function-associated antigen 1 in homotypic leukocyte adhesion stimulated by phorbol ester.

Authors:  R Rothlein; T A Springer
Journal:  J Exp Med       Date:  1986-05-01       Impact factor: 14.307

View more
  3 in total

1.  Factor(s) required by EBV transformed lymphocytes to grow under limiting dilution conditions.

Authors:  C Negri; R Chiesa; G C Ricotti
Journal:  Cytotechnology       Date:  1991-11       Impact factor: 2.058

2.  A growth factor different from IL-6 promotes the growth of Epstein-Barr virus-transformed cells at low cell density.

Authors:  C Negri; A Cerino; R Chiesa E; G C Astaldi Ricotti
Journal:  Cytotechnology       Date:  1991-02       Impact factor: 2.058

3.  Monoclonal antibodies from Epstein-Barr virus-transformed lymphocytes of common marmosets (Callithrix jacchus) immune to malaria.

Authors:  D A Johnston; A M Knight; B A Naylor; N Wedderburn; G H Mitchell
Journal:  J Immunol Methods       Date:  1990-03-09       Impact factor: 2.303

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.